Business
Press Release Jun 15 2021
Cipla Limited has informed the Exchange regarding a press release dated Jun 14, 2021, titled "Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol ".
About this update from Cipla Ltd
[{"type":"text","content":" Cipla Limited has informed the Exchange regarding a press release dated Jun 14, 2021, titled \"Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol \". View Attachment","length":335,"tagName":"div"}]